Added to YB: 2019-03-01
Pitch date: 2019-03-01
ALEC:US [bullish]
Alector, Inc.
-90.5%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Alector, Inc., a clinical stage biotechnology company, develops therapies to counteract the progression of neurodegeneration in the United States.
Market Cap
$238.7M
Pitch Price
$21.69
Price Target
N/A
Dividend
N/A
EV/EBITDA
-0.57
P/E
-1.81
EV/Sales
3.62
Sector
Biotechnology
Category
N/A
Show full summary:
ALECTOR INC COM ALEC:US
A summary for this pitch has not been created yet.
Read full article (0 min)